公司资料
Acutus Medical 股价、新闻与催化剂
- 股票代码:
- AFIB
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (-50.00%)
收盘价
最后更新: 2026年8月12日
—
市值
股价为何变动
Current closing-price context is not available for AFIB.
公司概览
业务概览
Acutus Medical is a medical technology company focused on electrophysiology mapping and ablation tools for cardiac arrhythmia procedures. Its business is tied to device adoption in interventional cardiology rather than drug development.
所在地与行业分类
Acutus Medical is headquartered in the United States and listed on NASDAQ, with a medtech profile centered on electrophysiology. It sits outside biotechnology.
商业模式特征
The company depends on procedure volume, device placements, reimbursement, and the ability to prove that its tools improve workflow in EP labs. Investors usually focus on adoption, capital sales, and execution risk.
生物医药行业定位
Acutus belongs to the cardiac-device layer of healthcare, not biotech. Its stock is driven by medtech commercialization and clinical adoption rather than by trial data or approvals.
未来催化剂
- Acutus Medical’s catalysts are EP mapping and ablation system adoption, plus any strategic update that clarifies whether the business can stabilize. The market will care about procedural utilization.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。